CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-11). The draft was written by AI, the existence of all 4 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 285 · Search date 2026-07-11 · Methodology v0.6

Fennel seed extract,
does it really help with Relief of menopausal symptoms?

30-Second Summary
C
Evidence Grade C · 52 · Safety caution
There are signals of improvement in overall menopausal-symptom scores, but results across small trials are inconsistent
What the
research shows
Two eight-week RCTs reported improved overall menopausal-symptom scores, but a three-month RCT found no difference from placebo, and sleep, anxiety, and depression outcomes in separate trials were mostly null. All trials were small and from one country, and some received product support, resulting in C with 52 points.
What the
ads claim
Marketing groups phytoestrogen activity and relief of hot flashes, night sweats, sleep, mood, and sexual desire as one established effect. Trials used different powders, softgels, standardization levels, and questionnaires, and results for individual symptoms were inconsistent.
*

Useful facts when choosing a product

  • Trial formulations ranged from fennel softgels at 200-300 mg/day to fennel seed powder at 2 g/day.
  • Positive outcomes mainly involved self-reported scales such as the MRS and Kupperman index.
  • Barij Essence supplied study products in some trials.
  • Human trial durations were mainly eight weeks to three months.
Gap Measurement · Verdict 285 · C 52
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The Rahimikian 2017 triple-blind RCT gave 90 postmenopausal women 100 mg fennel softgels twice daily for eight weeks and reported lower MRS scores than placebo at weeks 4, 8, and 10. The Ghaffari 2020 RCT gave 80 women fennel seed powder 2 g/day for eight weeks and reported a better Kupperman score, but between-group differences in estradiol and sexual desire were null. The Ghazanfarpour 2018 RCT gave 50 women 100 mg capsules three times daily for three months and found no placebo-adjusted difference in the main menopausal symptoms. The 50-person Afiat 2018 trial also found no significant difference in total PSQI or most sleep subscales.

02

Why this is classified as C (52)

Several randomized trials assessed clinical symptom scales, but sample sizes were 50-90 and results were split between positive and null. Regional concentration, formulation differences, and product support support C with 52 points.

Counterpoint. Two placebo-controlled trials reported improvements in overall menopausal-symptom scores, leaving a signal for independent replication.

Rejudgment record. New verdict — Several small RCTs exist, but overall menopausal scores are split between positive and null and individual symptoms are inconsistent, producing limited and conflicting evidence

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Rahimikian F et al. 2017Randomized triple-blind placebo-controlled trial90Academic study with an author affiliated with the Barij Medicinal Herbs Research CenterMenopause Rating ScaleMRS scores were lower than placebo at weeks 4, 8, and 10 after 100 mg twice daily for eight weeks.Key
Ghazanfarpour M et al. 2018Randomized double-blind placebo-controlled trial50Supported by Mashhad University; capsules supplied by Barij EssenceMENQOL menopausal symptomsThere was no between-group difference for the main menopausal symptoms.Key
Ghaffari P et al. 2020Randomized placebo-controlled trial80Unknown; Iranian academic institutionsKupperman index, sexual desire, and serum estradiolThe symptom score improved, but between-group differences in sexual desire and estradiol were null.Supportive
Afiat M et al. 2018Randomized double-blind placebo-controlled trial50Capsules supplied by Barij EssencePittsburgh Sleep Quality IndexNo between-group difference appeared in total PSQI or most subscales.Supportive
§

Receipt — 4 References

All 4 cited sources were verified for existence at the original page (as of 2026-07-11).

Rahimikian F, Rahimi R, Golzareh P, Bekhradi R, Mehran A. 2017. Effect of Foeniculum vulgare Mill. (fennel) on menopausal symptoms in postmenopausal women: a randomized, triple-blind, placebo-controlled trial. Menopause. 24(9):1017-1021. PMID: 28509813. DOI: 10.1097/GME.0000000000000881.
checked
Ghazanfarpour M, Najafi MN, Sharghi NB, Mousavi MS, Babakhanian M, Rakhshandeh H. 2018. A double-blind, placebo-controlled trial of Fennel (Foeniculum vulgare) on menopausal symptoms: A high placebo response. J Turk Ger Gynecol Assoc. 19(3):122-127. PMID: 29755029. DOI: 10.4274/jtgga.2017.0124.
checked
Ghaffari P, Hosseininik M, Afrasiabifar A, et al. 2020. The effect of Fennel seed powder on estradiol levels, menopausal symptoms, and sexual desire in postmenopausal women. Menopause. 27(11):1281-1286. PMID: 33110044. DOI: 10.1097/GME.0000000000001604.
checked
Afiat M, Rajab Dizavandi F, Kargarfard L, Mosavi Vahed SH, Ghazanfarpour M. 2018. Effect of Foeniculum Vulgare (Fennel) on Sleep Quality of Menopausal Women: A Double-blinded, Randomized Placebo-controlled Trial. J Menopausal Med. 24(3):204-209. PMID: 30671414. DOI: 10.6118/jmm.2018.24.3.204.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-11 · Corrections: none

Cite this verdict

Fennel seed extract x Relief of menopausal symptoms Evidence Grade C card
[Chamgap] Fennel seed extract x Relief of menopausal symptoms — Evidence Grade C·52. 4 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/womens/fennel-seed-menopause/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.